Piechota, W.; Krzesiński, P.; Piotrowicz, K.; Gielerak, G.; Kurpaska, M.; Rączka, A.; Woźniak-Kosek, A.
Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome. J. Clin. Med. 2022, 11, 3471.
https://doi.org/10.3390/jcm11123471
AMA Style
Piechota W, Krzesiński P, Piotrowicz K, Gielerak G, Kurpaska M, Rączka A, Woźniak-Kosek A.
Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome. Journal of Clinical Medicine. 2022; 11(12):3471.
https://doi.org/10.3390/jcm11123471
Chicago/Turabian Style
Piechota, Wiesław, Paweł Krzesiński, Katarzyna Piotrowicz, Grzegorz Gielerak, Małgorzata Kurpaska, Alicja Rączka, and Agnieszka Woźniak-Kosek.
2022. "Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome" Journal of Clinical Medicine 11, no. 12: 3471.
https://doi.org/10.3390/jcm11123471
APA Style
Piechota, W., Krzesiński, P., Piotrowicz, K., Gielerak, G., Kurpaska, M., Rączka, A., & Woźniak-Kosek, A.
(2022). Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome. Journal of Clinical Medicine, 11(12), 3471.
https://doi.org/10.3390/jcm11123471